financetom
Business
financetom
/
Business
/
Compounded semaglutide poses serious U.S. health issue, Novo Nordisk CEO says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Compounded semaglutide poses serious U.S. health issue, Novo Nordisk CEO says
Mar 8, 2024 2:43 AM

COPENHAGEN, March 8 (Reuters) - Novo Nordisk's

CEO on Friday said compounded semaglutide in the

United States is a serious health issue.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Intapp Insider Sold Shares Worth $358,978, According to a Recent SEC Filing
Intapp Insider Sold Shares Worth $358,978, According to a Recent SEC Filing
Sep 4, 2025
04:13 PM EDT, 09/04/2025 (MT Newswires) -- John T Hall, Director, Chief Executive Officer, on September 02, 2025, sold 8,000 shares in Intapp ( INTA ) for $358,978. Following the Form 4 filing with the SEC, Hall has control over a total of 5,598,775 common shares of the company, with 5,598,775 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1565687/000156568725000069/xslF345X05/form4.xml ...
Warner Bros Discovery sues AI photo generator Midjourney for stealing Superman, Scooby-Doo
Warner Bros Discovery sues AI photo generator Midjourney for stealing Superman, Scooby-Doo
Sep 4, 2025
* Midjourney accused of infringing copyrighted works * Warner Bros objects to 'breathtaking' piracy * Midjourney, lawyers not available for comment By Jonathan Stempel Sept 4 (Reuters) - Warner Bros Discovery ( WBD ) sued the AI photo generation company Midjourney on Thursday, saying it brazenly stole the studio's works to generate images of Batman, Superman, Wonder Woman, Bugs Bunny,...
Torrid Q2 net sales fall 7.7%, EBITDA misses estimates
Torrid Q2 net sales fall 7.7%, EBITDA misses estimates
Sep 4, 2025
Overview * Torrid fiscal Q2 net sales fall 7.7% to $262.8 mln, in line with company guidance but ahead of analysts' expectations * Adjusted EBITDA for fiscal Q2 misses analysts' expectations, per LSEG data * Net income for fiscal Q2 declines to $1.6 mln from $8.3 mln last year Outlook * Torrid expects Q3 net sales between $235 mln and...
Argan Q2 revenue misses analyst expectations
Argan Q2 revenue misses analyst expectations
Sep 4, 2025
Overview * Argan, which provides services in power industry, posts 4.7% rise in Q2 revenue, but misses analyst expectations * Adjusted EPS for fiscal Q2 was $2.50 * Company reports record project backlog of $2.0 bln Outlook * Argan sees strong demand for capabilities across all business segments * Company positioned to benefit from demand for reliable energy resources *...
Copyright 2023-2026 - www.financetom.com All Rights Reserved